China’s Health Ministry Gets Authority Over SFDA
This article was originally published in PharmAsia News
Executive Summary
Drug regulation in China is now under the control of the country's Ministry of Health. The ministry took control of the State FDA, a move intended to improve the record of the agency that regulates pharmaceutical and food safety. The ministry also oversees China's hospitals and public health system. The State Council approved the change, which took effect immediately. The change means the ministry will be ultimate authority in matters of SFDA regulation, safety, policy and quality assessments. The move has its critics who are concerned about too much centralization leading to corruption and negligence. (Click here for more
You may also be interested in...
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.